Delivery Order SPE2DB25D3404-SPE2DB25FUPMW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,235.01 to AmerisourceBergen Drug Corp for Omnipaque 300 mg/ml vials (10 ml) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Omnipaque is a contrast medium used in medical imaging procedures, reflecting the company's role as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $3,381.60 to AmerisourceBergen Drug Corp for the supply of Omnipaque 350 mg/ml, a contrast media pharmaceutical product in 500ml Pluspak packaging. This firm fixed-price delivery order, awarded on July 24, 2025, represents a non-competitive, non-set-aside procurement with an ultimate completion date of July 25, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $7,504.83 to AmerisourceBergen Drug Corp for the supply of Omnipaque 300 mg/mL infusion bottles (100 mL units). This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by July 24, 2025. AmerisourceBergen Drug Corp will perform the delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract action...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,527.54 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the supply of OMNIPAQUE 300 MG/ML VIAL 10ML, a medical product, with a completion date of February 7, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,837.80 delivery order is for OMNIPAQUE 350 MG/ML intravenous infusion bottles, with a completion date of September 6, 2022. The contract is a firm-fixed price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,690.80 firm fixed-price delivery order is for the medical product "OMNIPAQUE 350 MG/ML PLUSPAK 500ML" and has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,690.80 firm fixed-price delivery order is for the supply of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a medical product, with a period of performance through February 5, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,690.80, is for the delivery of OMNIPAQUE 350 MG/ML PLUSPAK 500ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 5, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
- This federal contract award is for the delivery of Omnipaque 350 mg/ml infusion bottles (150 ml) to the Defense Logistics Agency (DLA). The $1,783.80 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 25, 2022 and was awarded on January 24, 2022. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant...
- This federal contract award is a delivery order valued at $1,200.00 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPAQUE 240 MG/ML VIAL 10ML, a pharmaceutical product, with a performance period through May 8, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUPMWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,003.30 to AmerisourceBergen Drug Corp for OMNIPAQUE 180 mg/ml vials (10 ml units), a contrast medium commonly used in medical imaging procedures. This competitively awarded, firm fixed-price delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader relationship with the Defense Logistics Agency. This delivery order falls under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle extending through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen supplies a wide range of medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency operations and other federal healthcare systems. The non-set-aside award reflects the contractor's demonstrated capability to meet federal medical procurement requirements through open competition and positions it as a critical vendor within the Defense Logistics Agency's Medical Supply Chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 7/30/25 |